Research Article

Prevalence of Mycobacterium tuberculosis in North Central Nigeria

Ajide, B.1*, Chuku, A.1, Lawson, L.2, Orole, K1, Adogo, L.1
1 Department of Microbiology, Federal University of Lafia, Nassarawa State, Nigeria
2 Sankil Research Institute, Bingham University, Karu, Nasarawa State, Nigeria
* Corresponding author: bukze2000@yahoo.com
Published: Dec, 2020
DOI: 10.67614/njm.2020.d783202u
Pages: 5325-5332

Abstract

Prevalence of Mycobacterium tuberculosis is on the increase in developing countries especially in Nigeria despite the availability of short course therapy that are inexpensive and effective. This study was carried out to determine the prevalence of M. tuberculosis in North central Nigeria. A total of 2800 sputum samples from suspected pulmonary TB patients attending secondary health care facilities across North central, Nigeria were collected and processed for the presence of M. tuberculosis using Gene Xpert. The result revealed a prevalence of M. tuberculosis of 13.25% among the studied patients. Patients aged 30-39 years had the highest prevalence of 39.08% with male respondents having 13.88% while females had 12.56%. Also, 20.6% of PTB patients were co-infected HIV. The prevalence of TB was 13.24% and 13.26% among alcoholic consumers and non-alcoholic consumers respectively and 14.2% and 12.8% among smokers and non-smokers respectively. The importance of education with regard to the occurrence of PTB in this study shows that respondent with secondary and primary education had the highest prevalence of 13.6%, followed closely by those with tertiary education (13.4%), the least were participants with no formal education (12.4%). Base on the quality of sputum as a reservoir for MTB, bloody stained sputum showed the highest prevalence of 19.90 % of PTB as compare to mucoid showing 12.50 % as the lowest. The study detected high prevalence of M tuberculosis causing PTB among new cases across the North Central states of Nigeria, and this could serve as a wakeup call to put more effort and channel resources that will lead to reduction of the prevalence of PTB.

Keywords

Prevalence Pulmonary Tuberculosis Sputum Gene Xpert

References

  1. Adu, M.E., Ezie, E., Isbor, C.N., Jemakalajah D.J. (2015). Prevalence of Mycobacterium tuberculosis in human immunodeficiency virus patients at ART Center Agbor, Nigeria. African Journal of Cellular Pathology, 4(5): 62-65
  2. Ahmad, T., and Zohaib, M. D. (2015). Prevalence of tuberculosis infection in general population of district (lower) Pakistan East. International Journal of Scientific Research 23 (1): 14-17, 10.
  3. Altet, N., Latorre, I, Jiménez-Fuentes, M.A., Maldonado, J., Molina, I., González-Díaz, Y., Domínguez, J. (2017). Assessment of the influence of direct tobacco smoke on infection and active TB management. Public Library of Science, 12 (8): e0182998.
  4. Atiiola, G., Randle, T., Obadara, T., Komolafe, I., Odutolu, S., Olomu, J., Adenuga, L. (2018). Epidemiology of HIV and Tuberculosis in pregnant women, South West Nigeria. J of Infection and Public Health, 11: 826-833.
  5. Audu, E.S., Gambo, M.S., Baba, I.A, and Hincal, E. (2015). Statistical Analysis of Tuberculosis in Jigawa State, North-Western Nigeria. Malaysian Journal of Medical and Biological Research, 2(3): 237-241.
  6. Bisallah, C.I., Rampal, L., Lye, M.S., Mohd-Sidik, S., Ibrahim, N., Iliyasu, Z. (2018). Effectiveness of health education intervention on improving knowledge, attitude, and practices regarding Tuberculosis among HIV patients in General Hospital Minna, Nigeria – A randomized control trial. Public Library of Science ONE, 13 (2): e0192276.
  7. Centre Disease Control. (2011) Reported Tuberculosis in the United States, 2011. Atlanta, Ga:U.S. Department of Health and Human Services, CDC; September 2012. www.cdc.gov/tb/statistics/reports/2011/default.htm. (Accessed March 4, 2019)
  8. Charles, A., Tinuade, O., Jonah, M, Mercy I., Ifechi, A., Christian I. (2016). HIV prevalence amongst pregnant women clients attending antenatal clinic at the Faith Alive Foundation and PMTCT Centre, Jos Plateau State. World Journal of AIDS, 6: 59–64.
  9. Eze, G.U., Aduh, U., Obiebi, I.P., Obodo, K.T. (2018). Profile and Treatment Outcomes of Patients with Tuberculosis: A Fiveyear Review of Patients on TOTS in Delta State, Nigeria DOI 30 (1): 34-46
  10. Egbe K., Ike A. C., Aleruchi C. (2016). Prevalence of Tuberculosis and Rifampicin Resistance Among Patients Seeking Medical Care in Nasarawa State, North Central Nigeria. Science Journal of Public Health, 4 (3): 214-218.
  11. Gyar, S.D., Dauda, E., Reuben C.R. (2014) Prevalence of Tuberculosis in HIV/AIDS patients in Lafia, Central Nigeria. International Journal of Current Microbiology and Applied Sciences, 3 (6): 831-838
  12. Hassan, A.O., Richard, O., Ogbuji, Q. C., Afolabi, S., Okwuonye, L.C., Kusimo, O. C., and Ladipo, O. A. (2017). Knowledge about Tuberculosis: A Precursor to Effective TB Control—Findings from a Follow-Up National KAP Study on Tuberculosis among Nigerians. Tuberculosis Research and Treatment, 6309092. Published online Sep 18.
  13. Joshua, O.O., Gospel, T.O., Emeka, U.E., Chukwuere. E. (2013). Nigerian National TB standard operating procedures manual for Laboratories. National Tuberculosis and Leprosy Control programme (NTBLCP), Ministry of health. American Society for Microbiology, 1st edition. 1-244.
  14. Kolade, E.E., Astola, O.G., Gabalola, T. V., Komolafe O. I. (2016). HIV–TB co-infection and associated risk factors among HIV positive patients at Olabisi Onabanjo University Teaching Hospital, Ogun State, South-West Nigeria. El Sevier. HIV& AIDS Review, 15 (2): 69-72.
  15. Lawson, L., Habib, A.G., Okobi, M.I, Idion, D., Olajide, I., Emenyonu, N., Ogiri, S. (2010). Pilot study on multidrug resistant tuberculosis in Nigeria. Annals of African Medicine, 9: 184-187.
  16. Lawson, L., Joshua, J.O., Olajide, I., Emenyonu, N., Bello, C.S., Olatunji, O.O., Thacher. T.D. (2008). Sex differences in the clinical presentation of urban Nigerian patients with pulmonary tuberculosis. West Africa Journal of Medicine, 27 (2): 82-86.
  17. Muhammad, A and Muhammad, S. A. (2018) Retrospective Study of HIV and Tuberculosis Co-Infection among HIV Sero-Positive Patients in Kano, Nigeria. ARC Journal of Immunology and Vaccines, 3 (3): 24-30.
  18. Ogbo, F. A., Ogeleka, P., Okoro, A., Otusanya, O.B., Ifegwu, I.K., Awosemo, O.A., Page. A (2018) Tuberculosis disease burden and associated risk factors in Nigeria, 1990-2016. Tropical Medicine and Health, 46: 34.
  19. Oladimeji, O., Tsoka-Gwegweni, J.M., Adkyinka, D.A., Makola, I., Mitonga, K.H., Udoh, E.E., Patrick, Hazangwe. (2018). Knowledge, attitude and perception of tuberculosis management among tuberculosis infected patients in resource constrained setting: field experience from Oyo state, South-West, Nigeria. Int J Community Med Public Health, 5 (5): 1694-706
  20. Sani, R. A., Garba, S. A., Oyeleke, S. B., Abalaka, M. E. (2015). Prevalence of Pulmonary Tuberculosis (PTB) in Minna and Suleja Niger State, Nigeria. American Journal of Medicine and Sciences, 5 (6): 287-291.
  21. Wambura, G. M., OtungahTom, C. O., Ondicho. G. (2018). Knowledge and perceptions of tuberculosis among patients in a pastoralist community in Kenya: a qualitative study. Pan African Medical Journal, 30 (237): 1-6.
  22. World Health Organization (2011). Ambient (Outdoor) Air Quality and Health. Fact Sheet No. 313. World Health Organization. Moving research findings into new WHO policies. http://www.who.int/mediacentre/factsheets/fs313/en/index.html). (Accessed May 2019).
  23. World Health Organisation. (2013). WHO recommendations, Tuberculosis Diagnostics Xpert MTB/RIF Test. http://who.int/hiv/laboratory/mtbrifinfo (Accessed March 28, 2019).
  24. World Health Organization (2018). TB/HIV fact sheet. Resistance in the World. Report No.4.prepublication. Available at http://who.int/hiv/pub/tb/en/ https://www.who.int/hiv/pub/tb/en/ (Accessed March,2019)
  25. World Health Organization. (2019). Global tuberculosis report 2019 Geneva: https://apps.who.int/iris/handle/10665/329368 WHO Reference Number: WHO/CDS/TB/2019.15. / (Accessed September 1, 2020)
  26. Yonge, S., Otieno, M., Sharma, R. and Nteka. S. (2017). Drug Susceptibility Patterns of Mycobacterium tuberculosis Isolates from Tuberculosis Patients in Coastal Kenya. Journal of Tuberculosis Research, 5: 201-219.
How to Cite

B., A., A., C., L., L., K, O., & L., A. (2020). Prevalence of Mycobacterium tuberculosis in North Central Nigeria. Nigerian Journal of Microbiology, 34(2), 5325-5332. https://doi.org/10.67614/njm.2020.d783202u

A. B., C. A., L. L., O. K, and A. L., "Prevalence of Mycobacterium tuberculosis in North Central Nigeria," Nigerian Journal of Microbiology, vol. 34, no. 2, pp. 5325-5332, December 2020. doi: 10.67614/njm.2020.d783202u

Share this article:
Facebook X / Twitter LinkedIn
Download PDF View Full Text (PDF) Back to Articles